JAY JONES: Open Payments
NPI 1740235308 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 16 payments from 11 companies in 2025. Trend: 2023 $201 · 2024 $101 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $71 |
| PFIZER INC. | 3 | $69 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Madrigal Pharmaceuticals | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Medtronic, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: PREVNAR 20, FREESTYLE LIBRE 3, SHINGRIX, REZDIFFRA, GEMTESA, ESPRIT, REXULTI, O-ARM.
Industry payments across TX — which companies pay providers there.
